Latest 8-K filings

Kairos Pharma announced compelling interim safety data from its Phase 1 trial of ENV-105 in combination with osimertinib for advanced EGFR-mutated lung cancer patients, showing zero Grade 3+ toxicities.

Community Trust Bancorp, Inc. announced record-breaking earnings for the second quarter of 2026, driven by strong net interest income and noninterest income growth.

Eos Energy Enterprises announced preliminary Q2 2026 results, expecting record revenue of $68-69 million and a backlog of $807 million, driven by increased manufacturing scale and commercial execution.

Genasys Inc. announced a Third Amendment to its Term Loan and Security Agreement, extending the loan maturity to July 2027 and amending warrant terms, aiming to provide financial flexibility for growth.

Profound Medical Corp. announced its TULSA Procedure will be featured in multiple presentations at the Society of Robotic Surgery Annual Meeting.

Morgan Stanley announced record net revenues of $21.3 billion and EPS of $3.46 for the second quarter of 2026, driven by strong performance across its Institutional Securities and Wealth Management divisions.

Johnson & Johnson announced robust second-quarter 2026 results, with sales reaching $25.3 billion and earnings per share at $2.27, leading the company to increase its full-year financial guidance.

Conagra Brands reported fourth quarter and full fiscal year 2026 results, including a significant goodwill and brand impairment charge, and announced a reduction in its quarterly dividend.

Senti Biosciences Holdings, Inc. announces a strategic merger with an affiliate of its largest stockholder, Celadon Partners, to spin off its Gene-Circuit pipeline, including SENTI-202, while retaining focus on Regulator Dial technology for future gene and cell therapies.

Worthington Steel has commenced a public delisting tender offer for remaining shares of Kloeckner & Co SE, offering EUR 11.00 per share.

Entegris, Inc. announced its board of directors has declared a quarterly cash dividend of $0.10 per share.

Hycroft Mining Holding Corporation announced the appointment of Michael Deal as Senior Vice President and Chief Operating Officer, effective August 24, 2026, bringing extensive experience in gold and silver operations.

Axsome Therapeutics announced the FDA has accepted its New Drug Application for AXS-12 (reboxetine) for treating cataplexy in narcolepsy, with a target action date of May 1, 2027.

Green Thumb Industries Inc. has amended its Articles of Incorporation to increase the shareholder meeting quorum requirement.

Pediatrix Medical Group provided a second quarter update, confirming a stable payor mix and reaffirming its full-year 2026 Adjusted EBITDA outlook of $280 million to $300 million.

Smith & Wesson Brands, Inc. hosted an investor day on July 15, 2026, detailing its strategic transformation, market share gains, and future growth initiatives.

The PNC Financial Services Group, Inc. announced robust second quarter 2026 financial results, highlighted by record revenue, net interest income, and fee income, alongside a significant increase in its common stock dividend.

BlackRock announced robust Q2 2026 financial results, driven by record AUM, significant net inflows, and strong revenue growth across its diverse business segments.

First Horizon Corporation announced a 12% year-over-year increase in net income available to common shareholders, reaching $260 million, with EPS of $0.54 for the second quarter of 2026.

The Bank of New York Mellon Corporation announced robust financial results for the second quarter of 2026, driven by broad-based revenue growth and improved profitability.

SemiLEDs Corporation announced it has regained compliance with Nasdaq's minimum stockholders equity requirement, avoiding potential delisting.

M&T Bank Corporation announced record diluted earnings per common share of $5.32 for the second quarter of 2026, driven by robust net interest income and noninterest income growth.

Artificial Intelligence Technology Solutions, Inc. reported Q1 FY2027 results showing a slight year-over-year revenue decrease, but significant growth from customers other than its largest, alongside narrowed operating losses and reduced cash usage.

Elevance Health reported strong second quarter 2026 results, exceeding expectations and leading to an increase in full-year guidance for both earnings per share and operating cash flow.

SemiLEDs Corporation announced a significant turnaround in its third quarter fiscal year 2026, with revenue jumping to $9.1 million and net income turning positive.

Fractyl Health announced one-year results from its REMAIN-1 Midpoint Cohort, showing its Revita DMR System maintained significant weight loss after GLP-1 discontinuation.

Laird Superfood, Inc. announced that its Chief Financial Officer, Anya Hamill, will resign effective August 31, 2026, with the company initiating a search for her replacement.

Viking Acquisition Corp. II announced that holders of its public units can elect to separately trade Class A ordinary shares and warrants starting July 20, 2026.

Vistra Corp. announced it cleared approximately 10,924 MW in the PJM Capacity Auction for the 2028/2029 planning year at a weighted average price of $325.00 per megawatt-day.

Talen Energy announced its results from the PJM Base Residual Auction for the 2028/2029 planning year, clearing 10,180 megawatts at $325 per megawatt-day.